iN1011-N17 Mesylate Capsule (Part 2) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

iN Therapeutics Co., Ltd.1

Indications

Nav 1.71
Dorsal Root Ganglion1
Post Herpetic Neuralgia1
Osteoarthritis1
Neuropathic Pain1

Other1 trial

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.